BS PD ISO/TR 17302-2015 PDF

BS PD ISO/TR 17302-2015 PDF

Nanotechnologies. Framework for identifying vocabulary development for nanotechnology applications in human healthcare

$147.32 $294.64 -50%
Publisher
isbn 9780580761195
Product Code: BS PD ISO/TR 17302
Stock In Stock
Published: 12/31/2015
Number of Pages: 30
File Size: 1 file, 2.7 MB

Available Options

Product Description

Nanotechnologies. Framework for identifying vocabulary development for nanotechnology applications in human healthcare

Scope: This Technical Report will not attempt a formal, comprehensive definition of “nanomedicine”. Instead, it will provide a taxonomic framework for the development of vocabulary for clinical applications of nanotechnologies in human healthcare. While it is understood that the origins of nanotechnologies for healthcare applications emerge from pre-clinical and translational research, the interest of this Technical Report is to determine where these technologies will impact the clinical value chain and the practice of medicine. This Technical Report is intended to facilitate communications between developers and users of nanotechnologies, deliverers and users of medicine including the pharmaceutical, research and medical communities, regulatory professionals, and additional organizations and individuals who might interact with these groups, including biotechnology, diagnostic, and medical device companies, the life sciences, patent attorneys and patent offices, institutional review boards, ethics review boards, and accreditation organizations. 2 Symbols and abbreviated terms nm nanometer 3 Framework 3.1 General The term “nanomedicine” is used by the scientific community and government agencies to describe a field that is relatively undefined in terms of the affected health care segments and the specific advances in nanotechnologies for biomedical applications. In addition, the relevant mechanisms currently associated with diagnosis and treatment in biological processes can be larger than approximately 100 nm (e.g. endocytosis). Several participants from the biological sciences work with 400 nm diameter particles as drug carriers, while others consider <1 000 nm or <500 nm as pertinent in exploring emerging applications. Overall, the products currently enabled by nanotechnologies that are available for commercial clinical use are characterized by in vitro bulk properties or systemic effects. Examples of nanosize objects of interest in healthcare applications are depicted i

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
BS PD ISO/TR 17302-2015 PDF

BS PD ISO/TR 17302-2015 PDF

$147.32 $294.64